News Focus
News Focus
icon url

biopharm

11/07/15 7:01 PM

#241925 RE: biopharm #241924

Gary E. Gilbert, MD
VA Boston Healthcare System, Harvard Medical School
Boston, MA
Platelet Phosphatidylserine Exposure, Survival and Blood Coagulation in Mice Lacking TMEM16F



Gary Gilbert.... I'm actually a bit surprised at this exposure into the VA Boston

----------------------------

Gary Gilbert

Principal Investigator at Research in blood coagulation, emphasizing membrane interface

Greater Boston Area
Research

Current
VA Boston Healthcare System, Harvard University, Research in blood coagulation, emphasizing membrane interface

Education
Tufts University

286
connections


Experience

Chief, Hematology and Oncology
VA Boston Healthcare System
2015 – Present (less than a year)VA Boston Healthcare System

Associate Prof of Medicine
Harvard University
2011 – Present (4 years)

Principal Investigator
Research in blood coagulation, emphasizing membrane interface
September 1989 – Present (26 years 3 months)VA Boston Healthcare System

My laboratory focuses on coagulation factor VIII and lactadherin a.k.a. mfg-e8. We are particularly interested in the manner in which chemical and physical changes of the membrane regulate coagulation activity of the blood
..
..
..
https://www.linkedin.com/pub/gary-gilbert/72/440/652

icon url

biopharm

06/27/16 5:38 PM

#267448 RE: biopharm #241924

Nagata is to Phosphatidylserine as Dmitry Gabrilovich is to MDSC's...and WHO knows, maybe many feared that Peregrine interfearedon many other Big Pharmas legacy.




Nagata is still at it and all the talk about PS exposure will all lead to PS Targeting

Cell Death
Gordon Research Conference

New Concepts in Cell Death Research: From Basic Mechanisms to Clinical Opportunities

Dates
July 3-8, 2016
Location
PGA Catalunya Business and Convention Centre
Girona, Spain

Site Information

Organizers
Chair:
Henning Walczak

Vice Chair:
Marion MacFarlane

6:00 pm - 6:15 pm Shigekazu Nagata (Osaka University, Japan)
"Molecular Mechanism of Apoptotic Phosphatidylserine Exposure"

9:40 am - 9:55 am Peter Vandenabeele (VIB, University of Ghent, Belgium)
"Role of RIPK3 in Cell Death and Inflammation"

https://www.grc.org/programs.aspx?id=12477